Loading…
Anthem Biosciences (ANTHEM)₹958.15+1.68%Biotechnology
At the end of the Jun 2026 quarter, Anthem Biosciences' shareholders were: promoters 71.40%, FIIs 2.55%, DIIs 13.51%, public 12.54%. Promoter holding is down 3.25 percentage points from 74.65% a quarter earlier. 0.00% of promoter shares were pledged. It had 1,73,230 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Promoters | 74.67% | 74.67% | 74.65% | 71.40% |
| FIIs | 1.65% | 1.36% | 1.27% | 2.55% |
| DIIs | 7.24% | 7.63% | 11.58% | 13.51% |
| Public | 16.44% | 16.34% | 12.50% | 12.54% |
| Promoter shares pledged | — | — | — | 0.00% |
| Number of shareholders | 2,17,627 | 1,99,443 | 1,80,175 | 1,73,230 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Ajay Bhardwaj | Promoter | 42.42% | −0.13 |
| Ishaan Bhardwaj | Promoter | 10.12% | −0.03 |
| Ganesh Sambasivam | Promoter | 8.16% | −0.02 |
| K C Ravindra | Promoter | 7.77% | −0.02 |
| Portsmouth Technologies Llc | Public | 2.74% | −0.01 |
| Hdfc Trustee Company Limited-Hdfc Flexi Cap Fund | DII | 2.42% | New |
| Satish S Sharma | Public | 2.28% | −0.01 |
| Malay Jiban Barua | Public | 2.24% | −0.01 |
| Rupesh Narharrao Kinekar | Public | 2.20% | −0.06 |
| Sbi Mnc Fund | DII | 1.77% | New |
| Quant Mutual Fund - Quant Mid Cap Fund | DII | 1.46% | −0.17 |
| Axis Elss Tax Saver Fund | DII | 1.18% | New |
| S Vijayalakshmi | Promoter | 1.02% | −0.01 |
| KEERTHI TRUST(Trustee is K C RAVINDRA) | Promoter | 1.00% | −0.01 |
| SWARA TRUST(Trustee is K C RAVINDRA) | Promoter | 1.00% | −0.01 |
| Aruna Ganesh | Promoter | Exited | −3.04 |
| Hdfc Mutual Fund - Hdfc Nifty Midcap 150 Etf | DII | Exited | — |
| Sbi Nifty Midcap 150 Index Fund | DII | Exited | — |
| Krithika Ganesh | Promoter | 0.00% | 0.00 |
Promoters held 71.40% of Anthem Biosciences at the end of the Jun 2026 quarter.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 2.55% (up 1.28 percentage points from 1.27% a quarter earlier) and domestic institutions (DIIs) held 13.51% (up 1.93 percentage points from 11.58% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Anthem Biosciences had 1,73,230 shareholders at the end of the Jun 2026 quarter.
Portsmouth Technologies Llc (Public) held 2.74% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.